Table 1.

Cell-cycle analysis performed by flow cytometry after treatment with ionizing radiation alone or in combination (6 hours before) with tumor necrosis factor–related apoptosis-inducing ligand (1 μg/mL). Analysis was performed 24 hours after irradiation

HELK562FriendErythroleukemic
blasts
Normal
erythroblasts
G1S/G2-MG1S/G2-MG1S/G2-MG1S/G2-MG1S/G2-M
Control 65 35 58 42 57 43 58 42 54 46 
1.5 Gy 37 63 39 61 45 55 46 54 44 56 
15 Gy 17 83 33 67 34 66 33 67 42 58 
TRAIL 57 43 58 42 55 45 54 46 53 47 
1.5 Gy before TRAIL 38 62 39 61 44 56 45 55 43 57 
15 Gy before TRAIL 15 85 30 70 35 65 36 64 40 60 
HELK562FriendErythroleukemic
blasts
Normal
erythroblasts
G1S/G2-MG1S/G2-MG1S/G2-MG1S/G2-MG1S/G2-M
Control 65 35 58 42 57 43 58 42 54 46 
1.5 Gy 37 63 39 61 45 55 46 54 44 56 
15 Gy 17 83 33 67 34 66 33 67 42 58 
TRAIL 57 43 58 42 55 45 54 46 53 47 
1.5 Gy before TRAIL 38 62 39 61 44 56 45 55 43 57 
15 Gy before TRAIL 15 85 30 70 35 65 36 64 40 60 

Data represent the means of 2 (erythroleukemic blasts), 4 (HEL, K562, and Friend cell lines) and 5 (normal erythroblasts) separate experiments, performed in duplicate. Fourteen percent of the observations fell within one SD of the means.

TRAIL indicates tumor necrosis factor–related apoptosis-inducing ligand.

Close Modal

or Create an Account

Close Modal
Close Modal